A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation

• Authors: Kelsey T Danley; Karen Schmitz; Ritu Ghai; Joy S Sclamberg; Lela E Buckingham; Kelly Burgess; Timothy Kuzel; Lydia Usha
• Collaborators: Advocate Christ Medical Center; Rush University Medical Center
• Journal: The Oncologist
• Date: 2021 - Oct